Analysis Tools|
Allele Symbol Allele Name Allele ID |
Rragatm2Dmsa targeted mutation 2, David Sabatini MGI:5638548 |
||||||||||||
| Summary |
2 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• mild reduction in ad libitum blood glucose levels in young mice
|
|
• increased reduction in glycaemia following injection of insulin in an insulin tolerance test
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• over 50% of mice die within 2-3 weeks after the start of tamoxifen treatment
|
|
• frequent apoptotic figures in small intestine after tamoxifen treatment
• small intestinal atrophy
|
|
• transiently lose about 20% of body weight within 1 week of tamoxifen injection
|
|
• expansion of myeloid cells spreads to peripheral tissues in mice that survive more than 2 weeks after tamoxifen treatment
|
|
• expansion of monocytes is accompanied by profound reduction in B lymphocytes and/or their progenitors
|
|
• accumulation of monocytes in the spleen and bone marrow
|
|
• expansion of myeloid cells is histopathologically reminiscent of histiocytic sarcoma
|
|
• frequent apoptotic figures in small intestine after tamoxifen treatment
• small intestinal atrophy
|
|
• frequent apoptotic figures in small intestine after tamoxifen treatment
|
|
• expansion of myeloid cells spreads to peripheral tissues in mice that survive more than 2 weeks after tamoxifen treatment
|
|
• expansion of monocytes is accompanied by profound reduction in B lymphocytes and/or their progenitors
|
|
• accumulation of monocytes in the spleen and bone marrow
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|
|
||
